COVID-19-Related Oral Manifestations: Early Disease Features?
Jazyk angličtina Země Dánsko Médium print-electronic
Typ dokumentu dopisy, komentáře
PubMed
32603497
PubMed Central
PMC7361211
DOI
10.1111/odi.13516
Knihovny.cz E-zdroje
Zobrazit více v PubMed
European Centre for Disease Prevention and Control (ECDC) (2014, December 13). Sensitivity and Specificity of a case definition. Field Epidemiology Manual Wiki. https://wiki.ecdc.europa.eu/fem/Pages/. Sensitivity and Specificity of a case definition aspx.
Ansari, R. , Gheitani, M. , Heidari, F. , & Heidari, F. (2020). Oral cavity lesions as a manifestation of the novel virus (COVID‐ 19): A letter‐to‐editor. Oral Diseases, 10.1111/odi.13465 PubMed DOI
Chaux‐Bodard, A.‐G. , Deneuve, S. , & Desoutter, A. (2020). Oral manifestation of Covid‐19 as an inaugural symptom? Journal of Oral Medicine and Oral Surgery, 26(2), 18. 10.1051/MBCB/2020011 DOI
Gagnier, J. J. , Kienle, G. , Altman, D. G. , Moher, D. , Sox, H. , Riley, D. , … Tugwell, P. (2013). The CARE guidelines: Consensus‐based clinical case reporting guideline development. BMJ Case Reports, 2013, bcr2013201554. 10.1136/bcr-2013-201554 PubMed DOI PMC
Martín Carreras‐Presas, C. , Amaro Sánchez, J. , López‐Sánchez, A. F. , Jané‐Salas, E. , & Somacarrera Pérez, M. L. (2020). Oral vesiculobullous lesions associated with SARS‐CoV‐2 infection. Oral Diseases, 1‐3. 10.1111/odi.13382 PubMed DOI PMC
Patel, J. , & Woolley, J. (2020). Necrotizing periodontal disease: Oral manifestation of COVID‐19. Oral Diseases, 10.1111/odi.13462 PubMed DOI PMC
Rocha, B. A. , Souto, G. R. , de Mattos Camargo Grossmann, S. , de Aguiar, M. C. F. , de Andrade, B. A. B. , Romañach, M. J. , & Horta, M. C. R. (2020). Viral enanthema in oral mucosa: A possible diagnostic challenge in the COVID‐19 pandemic. Oral Diseases, 10.1111/odi.13473 PubMed DOI PMC
Sakaida, T. , Isao, T. , Matsubara, A. , Nakamura, M. , & Morita, A. (2020). Unique skin manifestations of COVID‐19: Is drug eruption specific to COVID‐19? Journal of Dermatological Science, 10.1016/j.jdermsci.2020.05.002 PubMed DOI PMC
Viner, R. M. , & Whittaker, E. (2020). Kawasaki‐like disease: Emerging complication during the COVID‐19 pandemic. The Lancet, 395(10239), 1741–1743. 10.1016/s0140-6736(20)31129-6 PubMed DOI PMC
Von Elm, E. , Altman, D. G. , Egger, M. , Pocock, S. J. , Gøtzsche, P. C. , & Vandenbroucke, J. P. (2009). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. BMJ, 335(7624), 806–808. 10.1136/bmj.39335.541782.AD PubMed DOI PMC
Oral candidiasis in non-severe COVID-19 patients: call for antibiotic stewardship
COVID-19-Associated Mucormycosis (CAM): Case-Series and Global Analysis of Mortality Risk Factors
Self-case report of oral and skin lesions associated with positivity of COVID-19
Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers
Safety of ChAdOx1 nCoV-19 Vaccine: Independent Evidence from Two EU States
Oral candidiasis of COVID-19 patients: Case report and review of evidence
Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic
COVID-19 transient snoring (CVTS): Clinical and laboratory description
Oral Complications of ICU Patients with COVID-19: Case-Series and Review of Two Hundred Ten Cases
The manifestation of oral mucositis in COVID-19 patients: A case-series
